Jennifer Merjeski

Jennifer Merjeski is an accomplished professional in the pharmaceutical and healthcare industry with over 19 years of experience, currently serving as the Director of Hematology Sales Strategy and Operations at Bristol Myers Squibb since November 2010. In this role, Jennifer leads sales-driven communications, enhances cross-functional collaboration in hematology and oncology initiatives, and develops strategic plans for new projects such as Project Tuscany. Previous positions include Associate Director of Eliquis Professional Marketing, where Jennifer managed the cross-alliance launch of cancer data sets, and Senior Product Manager for oncology product launches, showcasing a strong record of successful strategic execution and team leadership across various therapeutic areas. Jennifer's career includes significant roles at Ortho-McNeil Pharmaceutical and Ethicon, demonstrating a consistent track record of performance and effective territory management, along with relevant academic credentials from the University of Pittsburgh.